<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04953481</url>
  </required_header>
  <id_info>
    <org_study_id>M2021023</org_study_id>
    <nct_id>NCT04953481</nct_id>
  </id_info>
  <brief_title>Home Care Needs and Current Nursing Status of Patients With Amyotrophic Lateral Sclerosis</brief_title>
  <official_title>Home Care Needs and Current Nursing Status of Patients With Amyotrophic Lateral Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to comprehensively investigate and analyze the home care needs&#xD;
      and status quo of ALS patients in China, and to clarify their home care needs and status quo,&#xD;
      so as to provide reference for the development of home care service planning and policy&#xD;
      measures for ALS patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Amyotrophic lateral sclerosis (ALS) is the most common type of motor neuron disease. It is&#xD;
      common in middle-aged and elderly people. Progressive skeletal muscle weakness, atrophy,&#xD;
      fascicular fibrillation, bulbar paralysis and pyramidal tract sign are the main clinical&#xD;
      manifestations. The survival time is usually 3-5 years. As the pathogenesis of ALS is not&#xD;
      fully understood, there is no specific treatment for ALS. The clinical treatment mode of most&#xD;
      patients with ALS is hospitalization at the end of the disease and maintenance treatment at&#xD;
      home during the disease progression. At present, there are few reports on the home care needs&#xD;
      and nursing status of ALS patients in China. This study is a cross-sectional survey. Based on&#xD;
      consulting the relevant literature and consulting experts' opinions, the researchers designed&#xD;
      the questionnaire of home care needs and nursing status of ALS patients, The convenience&#xD;
      sampling method was used to select 126-252 ALS outpatients, 126-252 ALS inpatients, and&#xD;
      126-252 ALS family members from a third class a general hospital in Beijing. The needs and&#xD;
      status of home care of ALS patients in China were comprehensively investigated and analyzed,&#xD;
      and the needs and status of home care were clarified, so as to provide reference for the&#xD;
      development of home care service planning and policy measures for ALS patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the Barthel index of ADL</measure>
    <time_frame>At the time of survey (day 0)</time_frame>
    <description>the Barthel index of ADL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Caregiver Burden Inventory, CBI</measure>
    <time_frame>At the time of survey (day 0)</time_frame>
    <description>Caregiver Burden Inventory, CBI</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">252</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <arm_group>
    <arm_group_label>Amyotrophic lateral sclerosis group</arm_group_label>
    <description>Patients with amyotrophic lateral sclerosis undergoing home care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Caregiver group</arm_group_label>
    <description>Caregivers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>survey</intervention_name>
    <description>The general information, home care status and functional status of ALS patients and family caregivers were collected.</description>
    <arm_group_label>Amyotrophic lateral sclerosis group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The outpatients, inpatients, discharged patients and their caregivers of ALS in a general&#xD;
        hospital in Beijing.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        -&#xD;
&#xD;
        The inclusion criteria of ALS patients:&#xD;
&#xD;
          1. They met the diagnostic criteria of Chinese guidelines for the diagnosis and treatment&#xD;
             of amyotrophic lateral sclerosis; ② Receiving care at home; ③ No cognitive impairment&#xD;
             (if the patient is unable to talk and write due to illness, the family members can&#xD;
             express it for the patient);&#xD;
&#xD;
             ④ Informed consent, willing to participate in this study;&#xD;
&#xD;
             ⑤ No mental illness.&#xD;
&#xD;
             The inclusion criteria of caregivers: ① the primary caregiver designated by the&#xD;
             patient was responsible for the primary care;&#xD;
&#xD;
               -  They are relatives of patients;&#xD;
&#xD;
                    -  No payment for care; ④ Informed consent, willing to participate in this&#xD;
                       study;&#xD;
&#xD;
                         -  No mental illness; ⑥ There was no cognitive impairment.&#xD;
&#xD;
             Exclusion Criteria:&#xD;
&#xD;
             -&#xD;
&#xD;
             Exclusion criteria of ALS patients:&#xD;
&#xD;
             ① severe physical diseases, such as malignant tumor, liver and kidney dysfunction,&#xD;
             etc;&#xD;
&#xD;
             ② They are participating in other intervention projects.&#xD;
&#xD;
             Exclusion criteria of caregivers:&#xD;
&#xD;
               -  severe physical diseases, such as malignant tumor, liver and kidney dysfunction,&#xD;
                  etc; ② They are participating in other intervention projects.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Baohua Li</last_name>
      <phone>15611908581</phone>
      <email>lianglbh@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 27, 2021</study_first_submitted>
  <study_first_submitted_qc>July 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2021</study_first_posted>
  <last_update_submitted>July 7, 2021</last_update_submitted>
  <last_update_submitted_qc>July 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

